SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-032355
Filing Date
2019-02-08
Accepted
2019-02-08 16:53:28
Documents
4
Effectiveness Date
2019-02-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d723453ds8.htm S-8 64727
2 EXHIBIT 5.1 d723453dex51.htm EX-5.1 4993
3 EXHIBIT 23.1 d723453dex231.htm EX-23.1 1433
4 EXHIBIT 99.1 d723453dex991.htm EX-99.1 106488
  Complete submission text file 0001193125-19-032355.txt   178659
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-229587 | Film No.: 19580665
SIC: 2834 Pharmaceutical Preparations